[Form 4] Camden National Corporation Insider Trading Activity

Rhea-AI Filing Summary

Camden National Corporation (CAC) Form 4 filing: Director Larry K. Haynes acquired 372 shares of CAC common stock on 06/20/2025 at $38.57 per share. The shares were issued under the company’s 2022 Equity & Incentive Plan in lieu of director fees, indicating a non-cash, share-based compensation election. Following the transaction, Haynes directly owns 2,127.398 CAC shares. No derivative securities were reported and no dispositions occurred.

The transaction reflects a modest insider purchase rather than a sale, suggesting continued alignment of the director’s personal holdings with shareholder interests. Because the amount represents a small fraction of outstanding shares and no additional material events accompanied the filing, the overall market impact is expected to be limited.

Positive

• Director acquired shares instead of receiving cash fees, signaling confidence and alignment with shareholders.

Negative

• Purchase size (372 shares, ≈$14k) is immaterial and unlikely to influence stock valuation.

Insights

Financial Analyst

TL;DR: Small insider buy, symbolic alignment; limited market impact.

The Form 4 shows Director Larry K. Haynes opting to receive board fees in equity, adding 372 shares at $38.57. Insider acquisitions, even modest, are generally viewed more favorably than sales because they align management incentives with shareholders. However, the purchase value (≈$14.3 k) is immaterial relative to CAC’s market capitalization, and Haynes’ post-transaction stake remains modest at just over 2.1 k shares. No derivative activity or multiple insiders involved further limits significance. Consequently, while directionally positive from a governance standpoint, the filing is not impactful for valuation or near-term trading.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Haynes Larry K

(Last) (First) (Middle)

2 ELM STREET

(Street)

CAMDEN ME 04843

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CAMDEN NATIONAL CORP [ CAC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/20/2025		A		372(1)	A	$38.57	2,127.398	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares acquired under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees.

Remarks:

	Christopher G. Hutchinson, POA	06/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Camden National (CAC) shares did Director Larry K. Haynes buy?

He acquired 372 shares on 06/20/2025.

At what price were the CAC shares acquired?

The Form 4 reports a purchase price of $38.57 per share.

What is Larry K. Haynes’ total direct ownership after the transaction?

After the acquisition, he owns 2,127.398 CAC shares directly.

Was the transaction part of Camden National’s equity compensation plan?

Yes, the shares were issued under the 2022 Equity & Incentive Plan as payment of director fees.

Does the filing report any share sales or derivative activity?

No. The Form 4 lists only a purchase of common stock; no sales or derivatives were reported.